🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 18 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2020 13,99 14,55 13,48 14,24 +2,15% 7,65% 568.100
28/02/2020 13,25 14,40 13,11 13,94 +0,00% 9,74% 1.049.000
27/02/2020 13,74 14,75 13,30 13,94 -0,92% 10,55% 954.900
26/02/2020 14,88 15,03 13,71 14,07 -4,42% 8,87% 1.161.000
25/02/2020 14,89 15,03 14,41 14,72 +0,14% 4,16% 2.172.300
24/02/2020 14,75 15,00 14,48 14,70 -3,80% 3,53% 922.000
21/02/2020 15,59 15,59 15,06 15,28 -1,36% 3,40% 557.500
20/02/2020 15,65 15,80 15,25 15,49 -1,53% 3,51% 631.400
19/02/2020 16,34 16,49 15,54 15,73 -3,50% 5,81% 956.100
18/02/2020 14,76 16,96 14,75 16,30 +9,76% 14,97% 1.419.400
14/02/2020 15,50 16,06 14,75 14,85 -3,63% 8,45% 1.857.700
13/02/2020 15,33 16,10 15,20 15,41 -0,13% 5,87% 2.039.300
12/02/2020 15,17 15,48 15,02 15,43 +2,19% 3,03% 1.048.300
11/02/2020 14,62 15,20 14,51 15,10 +3,57% 4,72% 985.000
10/02/2020 14,58 14,72 14,37 14,58 +0,00% 2,40% 476.100
07/02/2020 14,10 14,73 14,00 14,58 +3,40% 5,18% 1.120.100
06/02/2020 14,10 14,45 13,87 14,10 -0,21% 4,11% 788.900
05/02/2020 13,70 14,23 13,47 14,13 +4,20% 5,55% 1.521.100
04/02/2020 13,16 13,72 13,16 13,56 +4,71% 4,26% 748.300
03/02/2020 12,35 13,04 12,35 12,95 +5,28% 5,59% 720.500
31/01/2020 12,79 12,84 12,01 12,30 -4,35% 6,49% 1.384.600
30/01/2020 12,68 12,89 12,45 12,86 +0,55% 3,47% 1.050.500
29/01/2020 12,47 12,91 12,39 12,79 +3,48% 4,17% 816.500
28/01/2020 12,19 12,39 12,07 12,36 +2,74% 2,63% 251.600
27/01/2020 11,95 12,15 11,62 12,03 +0,17% 4,44% 750.400
24/01/2020 12,62 12,72 11,92 12,01 -5,13% 6,34% 499.100
23/01/2020 12,58 12,78 12,25 12,66 +0,88% 4,21% 447.500
22/01/2020 12,30 12,82 12,19 12,55 +3,38% 5,12% 413.400
21/01/2020 12,05 12,35 12,00 12,14 +0,00% 2,90% 791.400
17/01/2020 12,74 12,80 12,04 12,14 -3,73% 5,97% 775.800